Pro Medicus Limited (ASX:PME – Get Free Report) announced a interim dividend on Friday, February 14th,MarketIndexAU Dividends reports. Shareholders of record on Thursday, March 20th will be given a dividend of 0.25 per share on Thursday, March 20th. This represents a yield of 0.09%. The ex-dividend date of this dividend is Wednesday, February 26th. This is a positive change from Pro Medicus’s previous interim dividend of $0.18.
Pro Medicus Price Performance
The stock has a market capitalization of $29.16 billion, a PE ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56. The company has a current ratio of 5.98, a quick ratio of 4.39 and a debt-to-equity ratio of 1.10.
Insider Activity at Pro Medicus
In related news, insider Sam Hupert sold 1,000,000 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of A$256.73 ($163.52), for a total transaction of A$256,730,000.00 ($163,522,292.99). 51.20% of the stock is owned by insiders.
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
See Also
- Five stocks we like better than Pro Medicus
- The Significance of Brokerage Rankings in Stock Selection
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Why Are Stock Sectors Important to Successful Investing?
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
- Following Congress Stock Trades
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.